Tar Samad

Overview

Head of Global Research and Corporate Patents at Lundbeck, leading the company's expansion from small-molecule neurology into biotherapeutics including bispecifics, blood-brain barrier shuttles, and oligonucleotides. Tar Samad heads global research and corporate patents at Lundbeck encompassing all discovery activities (biology, small and large molecules), with the company serving 10 million daily patients in neurology, neurorare, and neuro-adjacent areas and growing its biologics pipeline. Lundbeck under Tar Samad fully outsources all biologic manufacturing (both upstream and downstream) and is evaluating build-vs-buy-vs-partner options as its pipeline grows to include bispecifics, blood-brain barrier shuttles entering the clinic, and oligonucleotides. (Segment 2 (05:00-10:00))